WO2016021523A1 - 殺菌剤及びその製造方法 - Google Patents
殺菌剤及びその製造方法 Download PDFInfo
- Publication number
- WO2016021523A1 WO2016021523A1 PCT/JP2015/071903 JP2015071903W WO2016021523A1 WO 2016021523 A1 WO2016021523 A1 WO 2016021523A1 JP 2015071903 W JP2015071903 W JP 2015071903W WO 2016021523 A1 WO2016021523 A1 WO 2016021523A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- aqueous solution
- ozone
- bactericidal agent
- producing
- inorganic aqueous
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/40—Peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F23/00—Mixing according to the phases to be mixed, e.g. dispersing or emulsifying
- B01F23/20—Mixing gases with liquids
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F23/00—Mixing according to the phases to be mixed, e.g. dispersing or emulsifying
- B01F23/20—Mixing gases with liquids
- B01F23/23—Mixing gases with liquids by introducing gases into liquid media, e.g. for producing aerated liquids
- B01F23/232—Mixing gases with liquids by introducing gases into liquid media, e.g. for producing aerated liquids using flow-mixing means for introducing the gases, e.g. baffles
- B01F23/2323—Mixing gases with liquids by introducing gases into liquid media, e.g. for producing aerated liquids using flow-mixing means for introducing the gases, e.g. baffles by circulating the flow in guiding constructions or conduits
- B01F23/23231—Mixing gases with liquids by introducing gases into liquid media, e.g. for producing aerated liquids using flow-mixing means for introducing the gases, e.g. baffles by circulating the flow in guiding constructions or conduits being at least partially immersed in the liquid, e.g. in a closed circuit
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F25/00—Flow mixers; Mixers for falling materials, e.g. solid particles
- B01F25/30—Injector mixers
- B01F25/31—Injector mixers in conduits or tubes through which the main component flows
- B01F25/312—Injector mixers in conduits or tubes through which the main component flows with Venturi elements; Details thereof
- B01F25/3121—Injector mixers in conduits or tubes through which the main component flows with Venturi elements; Details thereof with additional mixing means other than injector mixers, e.g. screens, baffles or rotating elements
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F25/00—Flow mixers; Mixers for falling materials, e.g. solid particles
- B01F25/40—Static mixers
- B01F25/45—Mixers in which the materials to be mixed are pressed together through orifices or interstitial spaces, e.g. between beads
- B01F25/452—Mixers in which the materials to be mixed are pressed together through orifices or interstitial spaces, e.g. between beads characterised by elements provided with orifices or interstitial spaces
- B01F25/4521—Mixers in which the materials to be mixed are pressed together through orifices or interstitial spaces, e.g. between beads characterised by elements provided with orifices or interstitial spaces the components being pressed through orifices in elements, e.g. flat plates or cylinders, which obstruct the whole diameter of the tube
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F25/00—Flow mixers; Mixers for falling materials, e.g. solid particles
- B01F25/40—Static mixers
- B01F25/45—Mixers in which the materials to be mixed are pressed together through orifices or interstitial spaces, e.g. between beads
- B01F25/452—Mixers in which the materials to be mixed are pressed together through orifices or interstitial spaces, e.g. between beads characterised by elements provided with orifices or interstitial spaces
- B01F25/4523—Mixers in which the materials to be mixed are pressed together through orifices or interstitial spaces, e.g. between beads characterised by elements provided with orifices or interstitial spaces the components being pressed through sieves, screens or meshes which obstruct the whole diameter of the tube
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F25/00—Flow mixers; Mixers for falling materials, e.g. solid particles
- B01F25/50—Circulation mixers, e.g. wherein at least part of the mixture is discharged from and reintroduced into a receptacle
- B01F25/51—Circulation mixers, e.g. wherein at least part of the mixture is discharged from and reintroduced into a receptacle in which the mixture is circulated through a set of tubes, e.g. with gradual introduction of a component into the circulating flow
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B13/00—Oxygen; Ozone; Oxides or hydroxides in general
- C01B13/10—Preparation of ozone
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/50—Treatment of water, waste water, or sewage by addition or application of a germicide or by oligodynamic treatment
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/72—Treatment of water, waste water, or sewage by oxidation
- C02F1/78—Treatment of water, waste water, or sewage by oxidation with ozone
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F23/00—Mixing according to the phases to be mixed, e.g. dispersing or emulsifying
- B01F23/20—Mixing gases with liquids
- B01F23/23—Mixing gases with liquids by introducing gases into liquid media, e.g. for producing aerated liquids
- B01F23/237—Mixing gases with liquids by introducing gases into liquid media, e.g. for producing aerated liquids characterised by the physical or chemical properties of gases or vapours introduced in the liquid media
- B01F23/2376—Mixing gases with liquids by introducing gases into liquid media, e.g. for producing aerated liquids characterised by the physical or chemical properties of gases or vapours introduced in the liquid media characterised by the gas being introduced
- B01F23/23761—Aerating, i.e. introducing oxygen containing gas in liquids
- B01F23/237613—Ozone
Definitions
- the present invention relates to a method for producing a bactericidal agent for sterilizing microorganisms such as bacteria, fungi and yeast-like fungi, and a bactericidal agent produced by the production method.
- Patent Document 1 discloses an ozone water characterized in that the bubble diameter is 50 to 500 nm and the bubble water is made of an aqueous solution containing ozone nanobubbles containing ozone. Is described.
- Patent Document 2 discloses a bittern ozone combined product and / or a bittern water component in which a part of bittern water component is combined with ozone in a solution containing bittern.
- a predetermined ozone water characterized in that it contains a bitten ozonated substance combined with ozone in the part, and is odorless and colorless.
- ozone water can be used for sterilization, etc.
- general ozone water produced by simply dissolving ozone in water will lose most of the dissolved ozone in about 1 to 2 hours after production if kept at room temperature.
- ozone water containing bittern has been developed.
- a bactericidal agent having a high bactericidal ability is required for various microorganisms.
- an object of the present invention is to provide a method for producing a bactericidal agent having a high bactericidal ability for sterilizing microorganisms such as viruses, bacteria, fungi and spores.
- the present invention has the following configuration.
- the present invention provides a method for producing a bactericide characterized by the following constitutions 1 to 12, and a bactericidal agent which comprises the following constitution 13.
- Configuration 1 of the present invention includes a step of preparing an inorganic aqueous solution containing an inorganic component using seawater as a raw material, an ozone mixing step of mixing ozone with the inorganic aqueous solution, and stirring the inorganic aqueous solution mixed with ozone to generate bubbles.
- a method for producing a bactericide including a stirring step that passes through a nozzle, wherein the amount of inorganic aqueous solution to be treated in the ozone mixing step and the stirring step is X liter, and the processing speed of the ozone mixing step and the stirring step is Y It is a method for producing a bactericide, wherein the bactericide is produced by alternately repeating the ozone mixing step and the stirring step for A ⁇ X / Y minutes (A is 10 or more) when liter / min is used. .
- a bactericidal agent having a high bactericidal ability for sterilizing microorganisms can be produced.
- Configuration 2 of the present invention is the method for producing a bactericide according to Configuration 1, wherein the temperature of the inorganic aqueous solution in the ozone mixing step and the stirring step is 0 ° C. to 30 ° C.
- a bactericidal agent having a higher bactericidal ability can be produced by setting the temperature of the inorganic aqueous solution in the ozone mixing step and the stirring step to a predetermined range.
- the structure 3 of this invention is a manufacturing method of the bactericide of the structure 1 or 2 with which the inorganic component contained in inorganic aqueous solution contains a sodium ion, magnesium ion, potassium ion, and calcium ion.
- a bactericidal agent having a high bactericidal ability can be reliably produced because the inorganic component contained in the inorganic aqueous solution contains sodium ions, magnesium ions, potassium ions and calcium ions. .
- the constitution 4 of the present invention is the sterilization according to the constitution 3, wherein the inorganic component contained in the inorganic aqueous solution further contains at least one ion selected from the group consisting of sulfur, boron, lithium, silicon, zinc, iron and strontium. It is a manufacturing method of an agent.
- a bactericidal agent having a high bactericidal ability can be more reliably produced because the inorganic component contained in the inorganic aqueous solution further contains the aforementioned ions.
- a fifth aspect of the present invention is the method for producing a bactericide according to any one of the first to fourth aspects, wherein the inorganic aqueous solution is bittern-containing water.
- an inorganic component for obtaining a bactericidal agent having a high bactericidal ability can be supplied because the inorganic aqueous solution is bittern-containing water.
- a sixth aspect of the present invention is the method for producing a bactericide according to any one of the first to fifth aspects, wherein the inorganic aqueous solution does not contain an organic substance.
- the organic matter content in the inorganic aqueous solution can be made 1 ppm or less so that the organic matter is not substantially mixed in the bactericidal agent. As a result, it is possible to prevent a decrease in the sterilizing ability of the sterilizing agent due to the organic matter.
- Configuration 7 of the present invention is the method for producing a bactericide according to any one of Configurations 1 to 6, wherein the bubble generating nozzle is a bubble generating nozzle for generating microbubbles.
- the ozone mixed in the inorganic aqueous solution is made into a fine bubble like microbubbles by using a bubble generating nozzle capable of generating microbubbles in the stirring step. Can do. As a result, a disinfectant with a higher disinfecting ability can be produced more reliably.
- Configuration 8 of the present invention is the method for producing a bactericide according to any one of configurations 1 to 7, wherein the bactericide is a bactericide for sterilizing at least one of a virus, a bacterium, a fungus, and a spore. . Since the bactericidal agent produced by the production method of the present invention exhibits a bactericidal ability against predetermined microorganisms such as viruses, bacteria, fungi and spores, it can be used as a bactericidal agent for sterilizing these microorganisms.
- the bactericidal agent produced by the production method of the present invention exhibits a bactericidal ability with respect to spores that have conventionally been difficult to sterilize, and thus can be used as a bactericidal agent for sterilizing spores.
- Configuration 9 of the present invention is the method for producing a bactericide according to Configuration 8, wherein the bactericide is a bactericide for sterilizing a virus that is a low pathogenic avian influenza virus (H3N3). Since the bactericidal agent produced by the production method of the present invention exhibits a bactericidal ability against low pathogenic avian influenza virus (H3N3), it can be used as a bactericidal agent for sterilizing low pathogenic avian influenza virus (H3N3). it can.
- the bactericides are Escherichia coli, Salmonella, Staphylococcus aureus, Enterococci, Campylobacter, Helicobacter cinerea, H. pylori, Vibrio cholerae, Vibrio parahaemolyticus, Bacillus anthracis (one seedling and two seedlings).
- Configuration 11 of the present invention is the method for producing a fungicide according to Configuration 8, wherein the fungicide is a fungicide for sterilizing a fungus that is Aspergillus flavus or a yeast-like fungus that is Candida albicans.
- the bactericidal agent produced by the production method of the present invention exhibits a bactericidal ability bactericidal ability against Aspergillus flavus or Candida albicans, and thus can be used as a bactericidal agent for sterilizing this.
- Composition 12 of the present invention is the method for producing a fungicide according to Structure 8, wherein the fungicide is a fungicide for sterilizing spores that are Bacillus subtilis.
- the bactericidal agent produced by the production method of the present invention exhibits a bactericidal ability against Bacillus subtilis, a spore that has conventionally been difficult to sterilize, and can be used as a bactericidal agent for sterilizing the spore.
- Configuration 13 of the present invention is a bactericide manufactured by the method for manufacturing a bactericide according to any one of configurations 1 to 7. According to the present invention, a disinfectant having a high disinfecting ability for disinfecting microorganisms can be obtained.
- a method for producing a bactericidal agent having a high bactericidal ability for sterilizing microorganisms such as viruses, bacteria, fungi and spores can be provided.
- the present invention is a method for producing a bactericide for sterilizing microorganisms such as viruses, bacteria, fungi and spores.
- ozone is mixed with an inorganic aqueous solution containing a predetermined inorganic component (ozone mixing step) and predetermined stirring (stirring step) is repeated for a predetermined time. It is characterized by carrying out.
- the temperature of the inorganic aqueous solution in the ozone mixing step and the stirring step is preferably 0 ° C. to 30 ° C.
- the bactericidal agent obtained by this invention can be used as a form of bactericidal aqueous solution.
- the predetermined time can be shown as A ⁇ X / Y minutes.
- X (liter) is the amount of inorganic aqueous solution to be treated (treatment amount)
- Y (liter / minute) is the treatment speed of the ozone mixing step and the stirring step.
- the ozone mixing step and the stirring step are performed by alternately circulating the inorganic aqueous solution along the water channel of the system. Therefore, X (liter) / Y (liter / minute) corresponds to the time required to perform one cycle of the ozone mixing step and the stirring step.
- A is a dimensionless number corresponding to the number of repetitions of the process, and A ⁇ 10.
- FIG. 1 an example of the bactericidal agent manufacturing apparatus 1 which can be used for the manufacturing method of the bactericide of this invention is shown.
- the disinfectant manufacturing apparatus 1 includes a storage tank 3 for storing an inorganic aqueous solution containing a predetermined inorganic component, and microbubbles for generating microbubbles having a particle diameter of 1.0 ⁇ m to 50 ⁇ m in the storage tank 3. And a generator 5.
- the microbubble generator 5 can include a casing (not shown).
- a pump 15 that is rotationally driven by a motor is mounted in the casing.
- a vortex pump or a cascade pump can be used as the pump 15.
- a suction port 17 of the pump 15 is connected to a storage tank 3 that stores an inorganic aqueous solution via a suction path 19.
- a gas suction path 21 for sucking ozone gas is branched and connected in the middle of the suction path 19. Since negative pressure is generated in the suction passage 19 due to the suction action of the pump 15, ozone can be sucked from the gas suction passage 21 into the suction passage 19 by connecting the gas suction passage 21 to the suction passage 19. Is possible.
- ozone supply means 23 is connected to the gas suction path 21.
- the ozone supply means 23 can be configured to allow oxygen supplied from an oxygen cylinder (not shown) to pass through the discharge region.
- the discharge port of the pump 15 is connected to the ozone dissolving device 29 via the connection path 27.
- the ozone dissolving device 29 includes a hermetically sealed container 31.
- An inflow pipe 33 connected to the connection path 27 is provided at a position on the upper side of the sealed container 31.
- the inner end (inlet) 35 of the inflow pipe 33 is preferably directed upward.
- the position of the inflow port 35 is slightly above the water surface in the state stored in the sealed container 31.
- a discharge valve 37 for discharging ozone and oxygen as excess gas in the liquid mixture (mixed water) that is flowed into the sealed container 31 by the pump 15 is provided at the upper part of the sealed container 31.
- the discharge valve 37 has a function of discharging excess gas from the upper part of the sealed container 31 and a function of maintaining the pressure in the sealed container 31 at a predetermined pressure higher than the atmospheric pressure.
- a check valve provided with a valve body 39 such as a ball can be used as the discharge valve 37.
- a fine hole is formed in the exhaust hole of the check valve used as the discharge valve 37 so that the pressure in the sealed container 31 does not drop significantly.
- an outflow pipe 41 is provided for flowing out the inorganic aqueous solution mixed with ozone in the sealed container 31 to the outside.
- the inorganic aqueous solution mixed with ozone flows out from the outlet 43 to the outlet pipe 41.
- a bubble generating nozzle 49 is connected to the outflow pipe 41 via a connection path (connection pipe) 47.
- the nozzle 49 includes a nozzle body 51 to which a connection pipe 47 is connected.
- a bubble generating cartridge 55 is detachably attached to a communication hole 53 that communicates with the connection pipe 47 in the nozzle body 51.
- the bubble generating cartridge 55 includes a cylindrical cartridge main body 57 having one end side closed by a wall and the other end side opened.
- a fine mesh member 59 and an orifice 61 having an appropriate number of small holes are sequentially inserted into the cartridge main body 57 from the opening on the other end side of the cartridge main body 57.
- the mesh member 59 and the orifice 61 are detachably fixed by screwing a ring-shaped fixture 63 such as a ring-shaped nut or snap ring.
- a pressure release chamber 65 is provided between the wall portion on one end side of the cartridge main body 57 and the net member 59.
- a plurality of through holes 67 having a smaller diameter than the orifice 61 are formed in the peripheral wall of the pressure release chamber 65.
- One end side of the cartridge body 57 protrudes from the communication hole 53 in the nozzle body 51 into the stirring chamber 69 formed of a large-diameter hole formed in the nozzle body 51.
- the through hole 67 of the cartridge main body 57 communicates with the stirring chamber 69.
- an inorganic aqueous solution containing an inorganic component using seawater as a raw material is first prepared (a step of preparing an inorganic aqueous solution).
- the prepared inorganic aqueous solution is supplied to the storage tank 3.
- the inorganic aqueous solution will be described later.
- ozone is mixed into the inorganic aqueous solution (ozone mixing step). Specifically, when the motor of the sterilizing agent manufacturing apparatus 1 is driven to rotate the pump 15, the inorganic aqueous solution in the storage tank 3 is sucked through the suction passage 19 and the gas passes through the gas suction passage 21. Sucked. This gas contains ozone and oxygen. Therefore, ozone is mixed with the inorganic aqueous solution.
- the inorganic aqueous solution mixed with ozone is stirred in the sealed container 31 and passed through the bubble generating nozzle 49 (stirring step).
- the stirring of the inorganic aqueous solution mixed with ozone can be performed as follows. That is, the inorganic aqueous solution sucked by the pump 15 of the sterilizing agent manufacturing apparatus 1 and the gas containing ozone and oxygen are stirred and mixed in the pump 15, and a part of ozone and oxygen is mixed and dissolved in the inorganic aqueous solution. .
- the inorganic aqueous solution in which ozone is mixed and dissolved is injected into the sealed container 31 of the ozone dissolving device 29 from the inlet 35 of the inlet pipe 33. In the vicinity of the upper part in the sealed container 31, the upper water is stirred by the jetted water, and a part of ozone (oxygen) is dissolved (contained).
- the inorganic aqueous solution in which ozone is mixed and dissolved is injected into the sealed container 31 of the ozone dissolving device 29, the inorganic aqueous solution is directed toward the inner wall by directing the inlet 35 toward the inner wall of the sealed container 31. And can be injected. By spraying the inorganic aqueous solution toward the inner wall, it is possible to more efficiently mix and dissolve ozone in the inorganic aqueous solution.
- the inorganic aqueous solution After stirring the inorganic aqueous solution mixed with ozone, the inorganic aqueous solution is passed through the bubble generating nozzle 49. Specifically, the inorganic aqueous solution in which ozone near the bottom 31B of the sealed container 31 is mixed and dissolved is supplied from the outflow pipe 41 of the sterilizing agent manufacturing apparatus 1 to the bubble generation nozzle 49 through the connection pipe 47.
- the pressure is released, so that the ozone and oxygen dissolved (contained) in the inorganic aqueous solution containing ozone are fine. Generated as bubbles.
- the generated fine bubbles are further refined by the mesh member 59 and are injected into the pressure release chamber 65. Since the pressure of the inorganic aqueous solution containing ozone is further released in the pressure release chamber 65, the dissolved (contained) gas is further generated as fine bubbles and collides with the wall on one end side of the pressure release chamber 65. And further refined.
- the inorganic aqueous solution containing ozone that has been jetted from the pressure release chamber 65 through the through hole 67 to the stirring chamber 69 is further subjected to pressure release to further generate fine bubbles.
- the bubbles in the inorganic aqueous solution are further refined by the stirring action, and become uniform microbubbles having a particle size of about 1 ⁇ m to 50 ⁇ m.
- the storage tank 3 is odorless and colorless. Is produced (manufactured).
- a disinfectant is manufactured by repeatedly performing a process and a stirring process for A * X / Y minutes (A is 10 or more).
- the present inventors have a high bactericidal ability for sterilizing microorganisms such as viruses, bacteria, fungi and spores by setting a predetermined inorganic aqueous solution mixed with ozone to the above-mentioned predetermined time. Has been found to produce the present invention.
- the ozone mixing step and the stirring step it is preferable to implement repeatedly and alternately. By repeating these steps continuously and alternately, a bactericidal agent having a high bactericidal ability can be produced. Further, the ozone mixing step and the stirring step can be intermittently repeated alternately.
- the amount (treatment amount) of the inorganic aqueous solution prepared in the step of preparing the inorganic aqueous solution and supplied to the storage tank 3 corresponds to X liter.
- an inorganic aqueous solution having a processing amount of X liter is mixed and stirred with ozone, the storage tank 3 of the sterilizing agent manufacturing apparatus 1, the pump 15 , The airtight container 31 and the pipes such as the inflow pipe 33 and the outflow pipe 41 connecting them.
- the ozone mixing step and the stirring step are alternately performed by circulating along the water channel of the system with respect to the inorganic aqueous solution. Therefore, the processing speed (Y liter / min) of the ozone mixing step and the stirring step is determined by the flow rate of the pump 15. By controlling the flow rate of the pump 15, the processing speed (Y liter / min) can be controlled.
- X (liter) / Y (liter / minute) corresponds to the time required to perform one cycle of the ozone mixing step and the stirring step.
- A is a dimensionless number corresponding to the number of processing repetitions.
- A is 10 or more, preferably 20 or more, preferably 20 to 150, more preferably 30 to 150, even more preferably 40 to 80, and particularly preferably 45 to 60.
- the ozone mixing step and the stirring step can be repeatedly performed by circulating the inorganic aqueous solution to the disinfectant manufacturing apparatus 1 by the pump 15 for the predetermined time described above. As a result, a bactericidal agent having a high bactericidal ability can be produced.
- the temperature of the inorganic aqueous solution in the ozone mixing step and the stirring step is preferably 0 ° C. to 30 ° C., can be 0 ° C. to 25 ° C., and 0 ° C. to 15 ° C. More preferably, it is 0 ° C. to 10 ° C., more preferably 2 ° C. to 9 ° C., and particularly preferably 3 ° C. to 6 ° C.
- a bactericidal agent having a higher bactericidal ability can be produced by setting the temperature of the inorganic aqueous solution in the ozone mixing step and the stirring step to a predetermined range.
- a temperature control mechanism for controlling the temperature of the inorganic aqueous solution circulating in the bactericide manufacturing apparatus 1 can be provided.
- the temperature control mechanism for example, as shown in FIG. 1, a heat exchange medium having a predetermined temperature such as a refrigerant is circulated between the temperature control mechanism main body 52 and the heat exchanger 50 a arranged in the storage tank 3. The temperature of the inorganic aqueous solution in the storage tank 3 can be controlled.
- the heat exchange medium in the temperature control mechanism main body 52 can be brought to a predetermined temperature by feedback based on the measured value of the temperature of the inorganic aqueous solution by a temperature sensor (not shown) arranged in the storage tank 3.
- the temperature control mechanism is preferably disposed in the storage tank 3 as shown in FIG. This is because a large volume of the inorganic aqueous solution is present in the storage tank 3 among the inorganic aqueous solutions circulating through the bactericide manufacturing apparatus 1.
- the heat exchanger 50a can be arrange
- a heat exchanger 50 b is also disposed in the suction path 19.
- a temperature control mechanism for controlling the temperature of an aqueous solution such as an inorganic aqueous solution is known.
- the bubble generating nozzle 49 is preferably a bubble generating nozzle 49 for generating microbubbles.
- the stirring step by using a bubble generating nozzle 49 as shown in FIG. 2, the ozone mixed in the inorganic aqueous solution can be made into a fine bubble like a microbubble. As a result, a disinfectant with a higher disinfecting ability can be produced more reliably.
- the inorganic aqueous solution contains an inorganic component using seawater as a raw material.
- the inorganic aqueous solution is subjected to a predetermined treatment, it is presumed that the inorganic component made from seawater and ozone are changed to a compound having a high sterilizing ability to obtain a sterilizing agent.
- the inorganic component contained in the inorganic aqueous solution preferably contains at least one selected from sodium ions, magnesium ions, potassium ions and calcium ions, and contains all of the above ions. More preferred. Moreover, it is preferable that the inorganic component contained in the inorganic aqueous solution further contains at least one ion selected from the group consisting of sulfur, boron, lithium, silicon, zinc, iron and strontium. As a result, a bactericidal agent having a high bactericidal ability can be reliably produced.
- the inorganic aqueous solution is preferably bittern-containing water.
- bittern is the remaining liquid after salt is deposited from seawater.
- the bittern contains sodium ion, magnesium ion, potassium ion and calcium ion, optionally at least one ion selected from the group consisting of sulfur, boron, lithium, silicon, zinc, iron and strontium. Therefore, bittern-containing water can be preferably used as the inorganic aqueous solution used in the method for producing the bactericide of the present invention.
- bittern-containing water for example, “Tenkai no bittern (trade name)” and “deep water bittern commercial use” (both manufactured by Ako Kasei Co., Ltd.) can be used. Moreover, there are few organic substances in deep sea water. When organic matter is contained in the bactericidal agent of the present invention, the bactericidal performance tends to be reduced. Therefore, as the inorganic aqueous solution used in the method for producing the bactericide of the present invention, bittern-containing water using deep seawater as a raw material. Is preferably used.
- the inorganic aqueous solution does not contain an organic substance.
- the sterilizing ability of the sterilizing agent is reduced.
- the content of the organic substance in the inorganic aqueous solution as low as possible (for example, 1 ppm or less), it is possible to prevent the organic substance from being substantially mixed in the disinfectant. As a result, it is possible to prevent a decrease in the sterilizing ability of the sterilizing agent due to the organic matter.
- the bactericidal agent produced by the method for producing a bactericidal agent of the present invention (hereinafter simply referred to as “the bactericidal agent of the present invention”) has a high bactericidal ability. Therefore, the disinfectant of the present invention can be used as a disinfectant for disinfecting at least one of microorganisms such as viruses, bacteria, fungi and spores.
- the bactericidal agent of the present invention can be used as a bactericidal agent for sterilizing viruses such as the low pathogenic avian influenza virus (H3N3).
- the fungicides of the present invention include Escherichia coli, Salmonella, Staphylococcus aureus, Enterococci, Campylobacter, Helicobacter cinerea, Pylori, Vibrio cholerae, Vibrio parahaemolyticus (one and two seedlings), Treponema It was confirmed that it can be used as a bactericidal agent for sterilizing bacteria such as genus bacteria and potulinus bacteria (potulinus type A and potulinus type B).
- the fungicide of the present invention can be used as a fungicide for sterilizing Aspergillus flavus and the like as fungi. Moreover, it was confirmed that the fungicide of the present invention can be used as a fungicide for sterilizing Candida albicans and the like as a yeast-like fungus. Moreover, it was confirmed that the bactericidal agent of the present invention can be used as a bactericidal agent for sterilizing Bacillus subtilis, Potulinus type A (spore), Potulinus type B (spore) and the like as spores.
- the bactericidal agent of this invention is effective as a bactericidal agent with respect to the above-mentioned bacteria etc., it is thought that it is effective as a bactericidal agent of anthrax. Therefore, the bactericidal agent produced by the production method of the present invention can be used as a bactericidal agent for the above-mentioned viruses, bacteria, fungi and spores.
- the disinfectant of the present invention is not limited to the above-described embodiment, and can be implemented in other forms by making appropriate changes. That is, instead of seawater, an inorganic component adjusted to simulate the components of seawater added to an H 2 O liquid that does not contain impurities such as pure water can be used as the inorganic aqueous solution.
- Example 1 Using the bactericidal agent production apparatus 1 shown in FIG. 1, the temperature of the inorganic aqueous solution to be treated is set to be kept at 4 ° C., and the treatment time is changed as shown in Table 1, so that the bactericidal agent of Experimental Example 1 is used. Manufactured. At that time, the bubble generation nozzle 49 for micro generation shown in FIG. 2 was used as the bubble generation nozzle 49. As shown in Table 1, the amount of the inorganic aqueous solution (treatment amount X) supplied to the storage tank 3 of the sterilizer manufacturing apparatus 1 is 12 liters. Moreover, the processing speed Y of the disinfectant manufacturing apparatus 1 is 10 liters / minute.
- the disinfectant was produced by changing the treatment time t from 15 minutes to 150 minutes.
- the ozone mixing step and the stirring step are continuously and alternately repeated.
- the ozone concentration of the manufactured disinfectant was measured by an ozone concentration sensor and the KI method.
- the bactericidal ability of the produced bactericidal agent was evaluated by “maximum dilution factor having bactericidal effect” described later. These measurements and evaluations were performed 24 hours after the production of the fungicide of Experimental Example 1. Meanwhile, the bactericidal agent of Experimental Example 1 was put in a container with a lid and stored in a 4 ° C. cool box with the lid covered.
- the ozone concentration sensor used was a model number OZ-20 ozone meter manufactured by Toa DKK Corporation.
- the KI method is a measurement method utilizing the liberation of I 2 from KI in the presence of an oxidizing agent.
- the reaction of ozone (O 3 ): iodine (I 2 ): sodium thiosulfate (Na 2 S 2 O 3 ) has a molar ratio of 1: 1: 2.
- starch is dissolved in 50 to 100 ml of water (distilled water) to prepare a starch solution.
- a hydrochloric acid solution is prepared by diluting hydrochloric acid (HCl) having a concentration of 35% five times.
- KI potassium iodide
- a bactericide 1 liter is placed in a 2 liter glass beaker, and 20 ml of starch solution, 20 ml of KI solution, and 10 ml of hydrochloric acid solution are placed in a beaker and mixed well to give a light purple color.
- the bactericidal agent of Experimental Example 1 was used against the Escherichia coli of the ATCC standard strain (ATCC No. 25922). Was diluted at a predetermined magnification and applied, and the number of remaining E. coli was measured. “> 300” described as “the number of bacteria after sterilization” in Table 1 indicates that the number of E. coli was not less than the measurement limit of the measuring apparatus, and that the bactericidal agent did not exhibit a bactericidal effect. To do.
- the sterilizing ability of the fungicide of Experimental Example 1 is shown as the number of bacteria remaining after sterilization with a predetermined fungicide.
- Table 1 when A is 10 or more, it can be said that the maximum dilution ratio having a bactericidal effect is 800 times or more and has a bactericidal ability as a bactericidal agent.
- Table 1 when A is 25 or more, the maximum dilution rate having a bactericidal effect is 1000 times or more, and it can be said that it has a better bactericidal ability as a bactericidal agent.
- A has a bactericidal ability as a bactericidal agent in the range of 10 to 150, preferably 20 to 150, more preferably 30 to 150. Moreover, when A was 50, it was confirmed that the maximum dilution rate which has a bactericidal effect shows the extremely high bactericidal capability of 4000 times. Therefore, when A is in the range of 40 or more, preferably in the range of 40 to 80, and more preferably in the range of 45 to 60, it can be said that a bactericidal agent exhibiting extremely high bactericidal ability can be produced.
- the measured value of ozone concentration by the KI method increased monotonously with the increase of A.
- the disinfection ability of the disinfectant of the present invention shows a peak disinfection ability with a maximum dilution ratio of 4000 times having a bactericidal effect when A is around 50 as described above. Therefore, even if the sterilizing agent of Experiment 1 contains ozone that can be detected by the KI method, it is presumed that only ozone does not show the sterilizing effect. Therefore, the disinfectant produced by the production method of the present invention is not simply ozone water, and ozone has some chemical bond with an inorganic component derived from seawater as a raw material, thereby exhibiting disinfecting ability. Guessed. However, the present invention is not limited to this assumption.
- Example 2 The bactericidal agent of Experimental Example 2 was produced in the same manner as Experimental Example 1 except that the set aqueous solution temperature of the inorganic aqueous solution to be treated was set to 10 ° C. Thereafter, the ozone concentration of the bactericide of Experimental Example 2 was measured by the ozone concentration sensor and the KI method in the same manner as in Experimental Example 1. Further, the “maximum dilution ratio having a bactericidal effect” of the bactericidal agent of Experimental Example 2 was measured. The results are shown in Table 2.
- the maximum dilution ratio having a bactericidal effect is 800 times or more and has a bactericidal ability as a bactericidal agent.
- the maximum dilution rate having a bactericidal effect is 1000 times or more, and it can be said that it has a better bactericidal ability as a bactericidal agent.
- A has a sterilizing ability as a sterilizing agent in the range of 10 to 150, preferably 20 to 150, more preferably 30 to 150.
- the sterilizing ability of the sterilizing agent of Experimental Example 2 shows a peak sterilizing ability with a maximum dilution ratio of 4000 times having a sterilizing effect when A is around 50 as described above. It became clear. Therefore, when A is in the range of 40 or more, preferably in the range of 40 to 80, and more preferably in the range of 45 to 60, it can be said that a bactericidal agent exhibiting extremely high bactericidal ability can be produced.
- Example 3 The fungicide of Experimental Example 3 was manufactured in the same manner as Experimental Example 1 except that the set aqueous solution temperature of the inorganic aqueous solution to be treated was set to 25 ° C. Thereafter, the ozone concentration of the bactericide of Experimental Example 3 was measured by the ozone concentration sensor and the KI method in the same manner as in Experimental Example 1. Further, the “maximum dilution rate having a bactericidal effect” of the bactericide of Experimental Example 3 was measured. The results are shown in Table 3.
- the maximum dilution factor having the bactericidal effect of Experimental Example 3 was about 1000 times, which was lower than that of Experimental Examples 1 and 2, but showed a bactericidal effect as a bactericide.
- Example 4 The fungicide of Experimental Example 4 was manufactured in the same manner as Experimental Example 1 except that the set aqueous solution temperature of the inorganic aqueous solution to be treated was set to 50 ° C. Thereafter, the ozone concentration of the bactericide of Experimental Example 4 was measured by the ozone concentration sensor and the KI method in the same manner as in Experimental Example 1. Further, the “maximum dilution ratio having a bactericidal effect” of the bactericidal agent of Experimental Example 4 was measured. The results are shown in Table 4.
- the maximum dilution factor having the bactericidal effect of the fungicide of Experimental Example 4 is about 500 times, which is lower than the fungicides of Experimental Examples 1 to 3, but can be said to show the bactericidal effect as a fungicide. Therefore, when A is 10 or more, it can be said that the bactericidal effect as a bactericidal agent is shown.
- H3N3 low pathogenic avian influenza virus
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Hydrology & Water Resources (AREA)
- Water Supply & Treatment (AREA)
- Environmental & Geological Engineering (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Wood Science & Technology (AREA)
- Environmental Sciences (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Dentistry (AREA)
- Agronomy & Crop Science (AREA)
- Zoology (AREA)
- Dispersion Chemistry (AREA)
- Virology (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Treatment Of Water By Oxidation Or Reduction (AREA)
- Toxicology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
本発明の構成1は、海水を原料とする無機成分を含む無機水溶液を用意する工程と、無機水溶液に、オゾンを混合する、オゾン混合工程と、オゾンを混合した無機水溶液を撹拌し、バブル発生ノズルを通過させる、撹拌工程と、を含む、殺菌剤の製造方法であって、オゾン混合工程及び撹拌工程で処理される無機水溶液の量をXリットル、オゾン混合工程及び撹拌工程の処理速度をYリットル/分とするとき、オゾン混合工程及び撹拌工程を、A・X/Y分間(Aは、10以上)、交互に繰り返して実施することにより殺菌剤を製造する、殺菌剤の製造方法である。
本発明の構成2は、オゾン混合工程及び撹拌工程における無機水溶液の温度が、0℃~30℃である、構成1に記載の殺菌剤の製造方法である。本発明の殺菌剤の製造方法において、オゾン混合工程及び撹拌工程における無機水溶液の温度を所定の範囲とすることによって、より殺菌能力の高い殺菌剤を製造することができる。
本発明の構成3は、無機水溶液に含まれる無機成分が、ナトリウムイオン、マグネシウムイオン、カリウムイオン及びカルシウムイオンを含む、構成1又は2に記載の殺菌剤の製造方法である。本発明の殺菌剤の製造方法では、無機水溶液に含まれる無機成分が、ナトリウムイオン、マグネシウムイオン、カリウムイオン及びカルシウムイオンを含むことにより、殺菌能力の高い殺菌剤を、確実に製造することができる。
本発明の構成4は、無機水溶液に含まれる無機成分が、さらに硫黄、ホウ素、リチウム、ケイ素、亜鉛、鉄及びストロンチウムからなる群から選択される少なくとも一つのイオンを含む、構成3に記載の殺菌剤の製造方法である。本発明の殺菌剤の製造方法では、無機水溶液に含まれる無機成分が、さらに上述のイオンを含むことにより、殺菌能力の高い殺菌剤を、より確実に製造することができる。
本発明の構成5は、無機水溶液が、にがり含有水である、構成1~4のいずれかに記載の殺菌剤の製造方法である。本発明の殺菌剤の製造方法では、無機水溶液が、にがり含有水であることにより、殺菌能力の高い殺菌剤を得るための無機成分を供給することができる。
本発明の構成6は、無機水溶液が有機物を含まない、構成1~5のいずれかに記載の殺菌剤の製造方法である。本発明の殺菌剤の製造方法では、無機水溶液の有機物の含有量を1ppm以下とすることにより、殺菌剤中に、有機物が実質的に混入しないようにすることができる。この結果、有機物による、殺菌剤の殺菌能力の低下を防止することができる。
本発明の構成7は、バブル発生ノズルが、マイクロバブルを発生するためのバブル発生ノズルである、構成1~6のいずれかに記載の殺菌剤の製造方法である。本発明の殺菌剤の製造方法では、撹拌工程において、マイクロバブルを発生することのできるバブル発生ノズルを利用することにより、無機水溶液に混合したオゾンをマイクロバブルのような微細な泡状にすることができる。この結果、より殺菌能力の高い殺菌剤を、より確実に製造することができる。
本発明の構成8は、殺菌剤が、ウイルス、細菌、真菌及び芽胞のうち少なくとも一つを殺菌するための殺菌剤である、構成1~7のいずれかに記載の殺菌剤の製造方法である。本発明の製造方法で製造された殺菌剤は、ウイルス、細菌、真菌及び芽胞等の所定の微生物に対して殺菌能力を示すので、これらの微生物を殺菌するための殺菌剤として用いることができる。特に、本発明の製造方法で製造された殺菌剤は、従来、殺菌が困難とされてきた芽胞に対して殺菌能力を示すので、芽胞を殺菌するための殺菌剤として用いることができる。
本発明の構成9は、殺菌剤が、低病原性鳥インフルエンザウイルス(H3N3)であるウイルスを殺菌するための殺菌剤である、構成8に記載の殺菌剤の製造方法である。本発明の製造方法で製造された殺菌剤は、低病原性鳥インフルエンザウイルス(H3N3)対して殺菌能力を示すので、低病原性鳥インフルエンザウイルス(H3N3)を殺菌するための殺菌剤として用いることができる。
図1に示す殺菌剤製造装置1を用いて、処理される無機水溶液の温度を4℃に保つように設定し、表1に示すように処理時間を変化させて、実験例1の殺菌剤を製造した。その際、バブル発生ノズル49として、図2に示すマイクロ発生用のバブル発生ノズル49を用いた。表1に示すように、殺菌剤製造装置1の貯留槽3に供給された無機水溶液の量(処理量X)は、12リットルである。また、殺菌剤製造装置1の処理速度Yは10リットル/分である。表1に示すように、処理時間tを、15分~150分まで変化させて、殺菌剤を製造した。このとき、処理の繰り返し回数に相当するA(=t・Y/X)は、表1に示す値となる。図1に示す殺菌剤製造装置1では、オゾン混合工程及び撹拌工程は、連続的に交互に繰り返して実施される。
(48/2)/158=X/(B/1000)×(158/100)により、
X=0.24B×10-3(g)=0.24Bmg(ppm)
となる。
処理される無機水溶液の設定水溶液温度を10℃に設定した以外は、実験例1と同様に、実験例2の殺菌剤を製造した。その後、実験例2の殺菌剤のオゾン濃度を、実験例1と同様に、オゾン濃度センサ及びKI法により測定した。また、実験例2の殺菌剤の「殺菌効果を有する最大希釈倍率」を測定した。その結果を表2に示す。
処理される無機水溶液の設定水溶液温度を25℃に設定した以外は、実験例1と同様に、実験例3の殺菌剤を製造した。その後、実験例3の殺菌剤のオゾン濃度を、実験例1と同様に、オゾン濃度センサ及びKI法により測定した。また、実験例3の殺菌剤の「殺菌効果を有する最大希釈倍率」を測定した。その結果を表3に示す。
処理される無機水溶液の設定水溶液温度を50℃に設定した以外は、実験例1と同様に、実験例4の殺菌剤を製造した。その後、実験例4の殺菌剤のオゾン濃度を、実験例1と同様に、オゾン濃度センサ及びKI法により測定した。また、実験例4の殺菌剤の「殺菌効果を有する最大希釈倍率」を測定した。その結果を表4に示す。
実験例2の殺菌剤のうち、処理時間50分(A=50)の殺菌剤と同じ殺菌剤を用いて、実験例5の殺菌剤を製造した。実験例5の殺菌剤を用いて、表5に示す各種の細菌等の微生物に対する殺菌有効性を評価した。実験例5の殺菌剤の評価を、上述の「殺菌効果を有する最大希釈倍率」を測定することによって行った。表5に、その結果を示す。表5から明らかなように、本発明の殺菌剤は、表5に示すすべての細菌等に対する殺菌剤として有効であることが確認された。また、別途、低病原性鳥インフルエンザウイルス(H3N3)に対する殺菌剤として有効であることが確認された。
1 殺菌剤製造装置
3 貯留槽(貯水槽)
5 マイクロバブル発生装置
13 モータ
15 ポンプ
17 吸引口
21 気体吸引路
23 オゾン供給手段
27 接続路
29 オゾン溶解装置
31 密閉容器
33 流入管
41 流出管
43 流出口
43F フランジ部材
47 接続路(接続管)
49 バブル発生ノズル
51 ノズル本体
53 連通穴
55 バブル発生カートリッジ
57 カートリッジ本体
59 網部材
61 オリフィス
63 固定具
65 圧力解放室
67 貫通孔
69 撹拌室
Claims (13)
- 海水を原料とする無機成分を含む無機水溶液を用意する工程と、
無機水溶液に、オゾンを混合する、オゾン混合工程と、
オゾンを混合した無機水溶液を撹拌し、バブル発生ノズルを通過させる、撹拌工程と、
を含む、殺菌剤の製造方法であって、
オゾン混合工程及び撹拌工程で処理される無機水溶液の量をXリットル、オゾン混合工程及び撹拌工程の処理速度をYリットル/分とするとき、オゾン混合工程及び撹拌工程を、A・X/Y分間(Aは、10以上)、交互に繰り返して実施することにより殺菌剤を製造する、殺菌剤の製造方法。 - オゾン混合工程及び撹拌工程における無機水溶液の温度が、0℃~30℃である、請求項1に記載の殺菌剤の製造方法。
- 無機水溶液に含まれる無機成分が、ナトリウムイオン、マグネシウムイオン、カリウムイオン及びカルシウムイオンを含む、請求項1又は2に記載の殺菌剤の製造方法。
- 無機水溶液に含まれる無機成分が、さらに硫黄、ホウ素、リチウム、ケイ素、亜鉛、鉄及びストロンチウムからなる群から選択される少なくとも一つのイオンを含む、請求項3に記載の殺菌剤の製造方法。
- 無機水溶液が、にがり含有水である、請求項1~4のいずれか1項に記載の殺菌剤の製造方法。
- 無機水溶液が有機物を含まない、請求項1~5のいずれか1項に記載の殺菌剤の製造方法。
- バブル発生ノズルが、マイクロバブルを発生するためのバブル発生ノズルである、請求項1~6のいずれか1項に記載の殺菌剤の製造方法。
- 殺菌剤が、ウイルス、細菌、真菌及び芽胞のうち少なくとも一つを殺菌するための殺菌剤である、請求項1~7のいずれか1項に記載の殺菌剤の製造方法。
- 殺菌剤が、低病原性鳥インフルエンザウイルス(H3N3)であるウイルスを殺菌するための殺菌剤である、請求項8に記載の殺菌剤の製造方法。
- 殺菌剤が、大腸菌、サルモネラ菌、黄色ブドウ球菌、腸球菌、カンピロバクター、ヘリコバクター・シネジ菌、ピロリ菌、コレラ菌、腸炎ビブリオ菌、炭疽菌(一苗株及び二苗株)、トレポネーマ属菌及びポツリヌス菌から選択される少なくとも一つの細菌を殺菌するための殺菌剤である、請求項8に記載の殺菌剤の製造方法。
- 殺菌剤が、Aspergillus flavusである真菌又はCandida albicansである酵母様真菌を殺菌するための殺菌剤である、請求項8に記載の殺菌剤の製造方法。
- 殺菌剤が、枯草菌である芽胞を殺菌するための殺菌剤である、請求項8に記載の殺菌剤の製造方法。
- 請求項1~7のいずれか1項に記載の殺菌剤の製造方法によって製造された殺菌剤。
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2016540205A JP6783141B2 (ja) | 2014-08-04 | 2015-08-03 | 殺菌剤及びその製造方法 |
CN202210245179.1A CN114600905A (zh) | 2014-08-04 | 2015-08-03 | 杀菌剂及其制造方法 |
DK15830743.9T DK3178324T3 (da) | 2014-08-04 | 2015-08-03 | Mikrobicid og fremgangsmåde til fremstilling af samme |
US15/500,604 US10842153B2 (en) | 2014-08-04 | 2015-08-03 | Microbicide and method for manufacturing same |
KR1020177005662A KR102386583B1 (ko) | 2014-08-04 | 2015-08-03 | 살균제 및 그 제조 방법 |
EP15830743.9A EP3178324B1 (en) | 2014-08-04 | 2015-08-03 | Microbicide and method for manufacturing same |
CN201580042063.6A CN106572661A (zh) | 2014-08-04 | 2015-08-03 | 杀菌剂及其制造方法 |
US17/074,953 US20210030007A1 (en) | 2014-08-04 | 2020-10-20 | Microbicide |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2014158862 | 2014-08-04 | ||
JP2014-158862 | 2014-08-04 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/500,604 A-371-Of-International US10842153B2 (en) | 2014-08-04 | 2015-08-03 | Microbicide and method for manufacturing same |
US17/074,953 Division US20210030007A1 (en) | 2014-08-04 | 2020-10-20 | Microbicide |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2016021523A1 true WO2016021523A1 (ja) | 2016-02-11 |
Family
ID=55263789
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2015/071903 WO2016021523A1 (ja) | 2014-08-04 | 2015-08-03 | 殺菌剤及びその製造方法 |
Country Status (7)
Country | Link |
---|---|
US (2) | US10842153B2 (ja) |
EP (1) | EP3178324B1 (ja) |
JP (2) | JP6783141B2 (ja) |
KR (1) | KR102386583B1 (ja) |
CN (2) | CN114600905A (ja) |
DK (1) | DK3178324T3 (ja) |
WO (1) | WO2016021523A1 (ja) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017150988A1 (en) * | 2016-03-04 | 2017-09-08 | Lutra As | Preparation containing sea water added a potassium compound |
WO2018021551A1 (ja) * | 2016-07-28 | 2018-02-01 | 株式会社Ihi | 廃水処理装置及び廃水処理方法 |
WO2019107341A1 (ja) | 2017-11-30 | 2019-06-06 | 株式会社オプトクリエーション | オゾンナノバブルの抗がん剤 |
WO2019124561A1 (ja) | 2017-12-21 | 2019-06-27 | 株式会社 オプトクリエーション | 口腔ケア方法及び口腔ケアシステム |
JPWO2019234962A1 (ja) * | 2018-06-08 | 2020-06-18 | 株式会社オプトクリエーション | 微細気泡液製造装置、微細気泡液製造方法及びオゾン微細気泡液 |
JPWO2020203698A1 (ja) * | 2019-03-29 | 2020-10-08 | ||
JP7521777B2 (ja) | 2019-05-07 | 2024-07-24 | 株式会社資源開発研究所 | 殺菌剤の製造方法及び保管方法 |
US12060288B2 (en) | 2016-07-28 | 2024-08-13 | Ihi Corporation | Wastewater treatment device and wastewater treatment method |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108771987B (zh) * | 2018-07-19 | 2023-11-10 | 苏州方舟环保科技有限公司 | 一种高浓度臭氧水的制造设备 |
US11904366B2 (en) | 2019-03-08 | 2024-02-20 | En Solución, Inc. | Systems and methods of controlling a concentration of microbubbles and nanobubbles of a solution for treatment of a product |
JP6806941B1 (ja) * | 2020-06-08 | 2021-01-06 | 株式会社エムテック | 気液混合装置 |
CN114749294B (zh) * | 2022-04-30 | 2023-09-08 | 南京佳华科技股份有限公司 | 一种纳米级气泡的发生喷头及发生*** |
CN115490360A (zh) * | 2022-09-13 | 2022-12-20 | 赫拉环境保护技术有限公司 | 一种环保型多级污水处理装置 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006068631A (ja) * | 2004-09-01 | 2006-03-16 | Shigen Kaihatsu Kk | 洗浄装置及び同装置に使用するバブル発生ノズル |
JP2007245075A (ja) * | 2006-03-17 | 2007-09-27 | Sharp Corp | 抗菌水生成装置 |
JP2009154076A (ja) * | 2007-12-26 | 2009-07-16 | Sk Holdings:Kk | 徐放性オゾン水及びその製造方法並びに装置 |
JP2012126649A (ja) * | 2010-12-13 | 2012-07-05 | Satoshi Anai | 膀胱癌増殖抑制用組成物 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5951921A (en) * | 1997-01-31 | 1999-09-14 | Core Corporation | Apparatus for producing ozone water |
US6207064B1 (en) * | 1999-07-12 | 2001-03-27 | Joseph Gargas | Ozone contact chamber |
JP4059506B2 (ja) | 2004-03-05 | 2008-03-12 | 独立行政法人産業技術総合研究所 | オゾン水およびその製造方法 |
CN2734237Y (zh) * | 2004-09-14 | 2005-10-19 | 李振清 | 臭氧水空气杀菌消毒机 |
CN101123872B (zh) * | 2005-02-21 | 2013-07-17 | 松村荣治 | 臭氧水生成装置、用于臭氧水生成装置的气液混合结构、臭氧水生成方法以及臭氧水 |
EP1859675A4 (en) | 2005-02-21 | 2012-10-03 | Nobuko Hagiwara | DEVICE FOR PRODUCING OZONE WATER, STRUCTURE FOR MIXING GAS AND WATER FOR USE IN THE DEVICE, PRODUCTION METHOD FOR OZONE WATER AND OZONE WATER |
JP5261569B2 (ja) | 2011-12-22 | 2013-08-14 | 株式会社 Skホールディングス | オゾン水及びその製造装置 |
-
2015
- 2015-08-03 CN CN202210245179.1A patent/CN114600905A/zh active Pending
- 2015-08-03 CN CN201580042063.6A patent/CN106572661A/zh active Pending
- 2015-08-03 KR KR1020177005662A patent/KR102386583B1/ko active IP Right Grant
- 2015-08-03 US US15/500,604 patent/US10842153B2/en active Active
- 2015-08-03 DK DK15830743.9T patent/DK3178324T3/da active
- 2015-08-03 EP EP15830743.9A patent/EP3178324B1/en active Active
- 2015-08-03 JP JP2016540205A patent/JP6783141B2/ja active Active
- 2015-08-03 WO PCT/JP2015/071903 patent/WO2016021523A1/ja active Application Filing
-
2020
- 2020-08-26 JP JP2020142525A patent/JP7082826B2/ja active Active
- 2020-10-20 US US17/074,953 patent/US20210030007A1/en not_active Abandoned
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006068631A (ja) * | 2004-09-01 | 2006-03-16 | Shigen Kaihatsu Kk | 洗浄装置及び同装置に使用するバブル発生ノズル |
JP2007245075A (ja) * | 2006-03-17 | 2007-09-27 | Sharp Corp | 抗菌水生成装置 |
JP2009154076A (ja) * | 2007-12-26 | 2009-07-16 | Sk Holdings:Kk | 徐放性オゾン水及びその製造方法並びに装置 |
JP2012126649A (ja) * | 2010-12-13 | 2012-07-05 | Satoshi Anai | 膀胱癌増殖抑制用組成物 |
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017150988A1 (en) * | 2016-03-04 | 2017-09-08 | Lutra As | Preparation containing sea water added a potassium compound |
WO2018021551A1 (ja) * | 2016-07-28 | 2018-02-01 | 株式会社Ihi | 廃水処理装置及び廃水処理方法 |
JPWO2018021551A1 (ja) * | 2016-07-28 | 2019-02-28 | 株式会社Ihi | 廃水処理装置及び廃水処理方法 |
US12060288B2 (en) | 2016-07-28 | 2024-08-13 | Ihi Corporation | Wastewater treatment device and wastewater treatment method |
US10626032B2 (en) | 2016-07-28 | 2020-04-21 | Ihi Corporation | Wastewater treatment device and wastewater treatment method |
US11279640B2 (en) | 2016-07-28 | 2022-03-22 | Ihi Corporation | Wastewater treatment device and wastewater treatment method |
JPWO2019107341A1 (ja) * | 2017-11-30 | 2020-07-16 | 株式会社オプトクリエーション | オゾンナノバブルの抗がん剤 |
WO2019107341A1 (ja) | 2017-11-30 | 2019-06-06 | 株式会社オプトクリエーション | オゾンナノバブルの抗がん剤 |
WO2019124561A1 (ja) | 2017-12-21 | 2019-06-27 | 株式会社 オプトクリエーション | 口腔ケア方法及び口腔ケアシステム |
KR20200092408A (ko) | 2017-12-21 | 2020-08-03 | 가부시키가이샤 오프토쿠리에션 | 구강 케어 방법 및 구강 케어 시스템 |
US11471387B2 (en) | 2017-12-21 | 2022-10-18 | Opt Creation Inc. | Oral cavity care method and oral cavity care system |
JP2019112324A (ja) * | 2017-12-21 | 2019-07-11 | 株式会社オプトクリエーション | 口腔ケア方法及び口腔ケアシステム |
KR20210018305A (ko) | 2018-06-08 | 2021-02-17 | 가부시키가이샤 오프토쿠리에션 | 미세 기포액 제조 장치, 미세 기포액 제조 방법 및 오존 미세 기포액 |
JPWO2019234962A1 (ja) * | 2018-06-08 | 2020-06-18 | 株式会社オプトクリエーション | 微細気泡液製造装置、微細気泡液製造方法及びオゾン微細気泡液 |
JPWO2020203698A1 (ja) * | 2019-03-29 | 2020-10-08 | ||
WO2020203698A1 (ja) * | 2019-03-29 | 2020-10-08 | 株式会社Ihi | オゾン水製造装置、オゾン水製造方法、オゾン水、オゾン水処理装置、および、評価方法 |
JP7521777B2 (ja) | 2019-05-07 | 2024-07-24 | 株式会社資源開発研究所 | 殺菌剤の製造方法及び保管方法 |
Also Published As
Publication number | Publication date |
---|---|
CN106572661A (zh) | 2017-04-19 |
US10842153B2 (en) | 2020-11-24 |
JP6783141B2 (ja) | 2020-11-11 |
EP3178324A1 (en) | 2017-06-14 |
US20210030007A1 (en) | 2021-02-04 |
JP2020196743A (ja) | 2020-12-10 |
KR20170039260A (ko) | 2017-04-10 |
EP3178324B1 (en) | 2020-09-23 |
US20170215428A1 (en) | 2017-08-03 |
CN114600905A (zh) | 2022-06-10 |
JP7082826B2 (ja) | 2022-06-09 |
KR102386583B1 (ko) | 2022-04-13 |
JPWO2016021523A1 (ja) | 2017-05-25 |
DK3178324T3 (da) | 2020-11-23 |
EP3178324A4 (en) | 2018-03-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7082826B2 (ja) | 殺菌剤及びその製造方法 | |
US10449263B2 (en) | Devices for disinfection, deodorization, and/or sterilization of objects | |
JP6122139B2 (ja) | 超微細気泡含有微酸性次亜塩素酸水溶液の製造方法及び使用方法 | |
AU2017271130B2 (en) | Hand disinfectant | |
US20170000821A1 (en) | Hand disinfectant | |
JP6214855B2 (ja) | 微細気泡含有の微酸性次亜塩素酸水、その製造方法及び使用方法 | |
JP2022121439A (ja) | 塩を電気分解して得られたものを原材料に用いた亜塩素酸水の製造方法 | |
JP2007246432A (ja) | 過オキシ酸の製造方法、それにより得られた過オキシ酸含有殺菌用水性組成物および医療用殺菌剤 | |
AU2004237836A1 (en) | Efficacy enhancers for germicides | |
JP2009154076A (ja) | 徐放性オゾン水及びその製造方法並びに装置 | |
JP5261569B2 (ja) | オゾン水及びその製造装置 | |
AU2004237835A1 (en) | Improved distribution and preparation of germicidal compositions | |
CN106689198A (zh) | 一种复方过氧化氢消毒剂及其制备方法和应用 | |
JP7521777B2 (ja) | 殺菌剤の製造方法及び保管方法 | |
WO2008038744A1 (fr) | Composition bactéricide | |
BE1023453B1 (nl) | Stabiele chloordioxidesamenstelling en bereidingswijze | |
JP2006232687A (ja) | 循環水系におけるバイオフィルムの形成抑制剤及びバイオフィルムの形成抑制方法 | |
BE1023120B1 (nl) | Werkwijze en systeem voor het desinfecteren met chloordioxide gas | |
JP2018198927A (ja) | 殺菌方法およびその装置 | |
EA044503B1 (ru) | Дезинфицирующее средство для рук |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 15830743 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2016540205 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 15500604 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
REEP | Request for entry into the european phase |
Ref document number: 2015830743 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2015830743 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 20177005662 Country of ref document: KR Kind code of ref document: A |